Anti-Smad2 antibody [EP567Y]
- 20ul selling size
- RabMAb
- Advanced Validation
- Recombinant
- KO Validated
- What is this?
4
(2 Reviews)
|
(94 Publications)
Rabbit Recombinant Monoclonal SMAD2 antibody. Suitable for ChIC/CUT&RUN-seq, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Mouse samples. Cited in 94 publications.
View Alternative Names
MADH2, MADR2, SMAD2, SMAD family member 2, SMAD 2, hSMAD2, JV18-1, Mad-related protein 2, Mothers against decapentaplegic homolog 2, hMAD-2, MAD homolog 2, Mothers against DPP homolog 2
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Smad2 antibody [EP567Y] (AB33875)
Immunocytochemistry/Immunofluorescent analysis of HeLa (human cervix adenocarcinoma epithelial) cells labeling Smad2 with ab33875 at a dilution of 1/500. ab150077, an Alexa Fluor® 488 goat anti-rabbit was used at 1/1000 was used as the secondary antibody. Cells were fixed with 4% Paraformaldehyde and permeabilised with 0.1% tritonX-100. Counterstain antibody : ab195889, anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at 1/200.
Secondary antibody only negative control is shown in the bottom panels.
Confocal image showing mainly nuclear staining on HeLa cells after the treatment with TGF-b (10ng/mL) for 1 hour.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Smad2 antibody [EP567Y] (AB33875)
Overlay histogram showingJurkat cells stained with purified ab33875 (pink line) at a dilution of 1/110. The cells were fixed with 2% PFA.FITC goat anti-rabbit was used at a dilution of 1/150 and rabbit monoclonal IgG was used as theisotype control (green line).
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Smad2 antibody [EP567Y] (AB33875)
Overlay histogram showing PC3 cells stained with unpurified ab33875 (red line). The cells were fixed with methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab33875, 1/100 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit monoclonal IgG (1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a decreased signal in PC3 cells fixed with 4% paraformaldehyde (10 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.
- WB
Lab
Western blot - Anti-Smad2 antibody [EP567Y] (AB33875)
Lanes 1 - 3 : Merged signal (red and green). Green - ab33875 observed at 52 kDa. Red - loading control, ab9484, observed at 37 kDa.
ab33875 was shown to specifically react with Smad2 in wild-type WT HeLa cells as signal was lost in SMAD2 knockout cells. Wild-type and SMAD2 knockout samples were subjected to SDS-PAGE. ab33875 and ab9484 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Smad2 antibody [EP567Y] (ab33875) at 1/1000 dilution
Lane 1:
Wild-type HeLa whole cell lysate at 20 µg
Lane 2:
SMAD2 knockout HeLa whole cell lysate at 20 µg
Lane 3:
A549 whole cell lysate at 20 µg
Predicted band size: 52 kDa
Observed band size: 52 kDa
false
- WB
Unknown
Western blot - Anti-Smad2 antibody [EP567Y] (AB33875)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Smad2 antibody [EP567Y] (ab33875) at 1/2000 dilution
All lanes:
Jurkat cell lysate at 10 µg
Secondary
All lanes:
HRP goat anti-rabbit (H+L) at 1/1000 dilution
Predicted band size: 52 kDa
Observed band size: 58 kDa
false
- WB
Lab
Western blot - Anti-Smad2 antibody [EP567Y] (AB33875)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Smad2 antibody [EP567Y] (ab33875) at 1/1000 dilution
All lanes:
Jurkat cell lysate at 10 µg
Secondary
All lanes:
HRP goat anti-rabbit (H+L) at 1/1000 dilution
Predicted band size: 52 kDa
Observed band size: 58 kDa
false
- WB
Lab
Western blot - Anti-Smad2 antibody [EP567Y] (AB33875)
Lanes 1 - 4 : Merged signal (red and green). Green - ab33875 observed at 58 kDa. Red - loading control, ab8245 observed at 37 kDa.
ab33875 was shown to react with Smad2 in wild-type HeLa. Loss of signal was observed when knockout cell line ab255430 (knockout cell lysate ab263833) was used. Wild-type and Smad2 knockout samples were subjected to SDS-PAGE. ab33875 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Smad2 antibody [EP567Y] (ab33875) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
Jurkat cell lysate at 20 µg
Lane 2:
Western blot - Human SMAD2 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-smad2-knockout-hela-cell-line-ab255430'>ab255430</a>)
Lane 3:
Wild-type HeLa cell lysate at 20 µg
Lane 4:
SMAD2 knockout HeLa cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution
Predicted band size: 52 kDa
Observed band size: 37 kDa,58 kDa
false
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-Smad2 antibody [EP567Y] (AB33875)
ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2.5 x 10^5 HaCaT (Human keratinocyte cell line) cells (treated with 7ng/ml TGF-β for 1h) and 5 µg of ab33875 [EP567Y]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. Additional screenshots of mapped reads can be found in the Protocol booklet in the Product Protocol section. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- WB
Lab
Western blot - Anti-Smad2 antibody [EP567Y] (AB33875)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Smad2 antibody [EP567Y] (ab33875) at 1/1000 dilution
All lanes:
RAW264.7 at 10 µg
Secondary
All lanes:
HRP goat anti-rabbit (H+L) at 1/1000 dilution
Predicted band size: 52 kDa
Observed band size: 58 kDa
false
- WB
Lab
Western blot - Anti-Smad2 antibody [EP567Y] (AB33875)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Smad2 antibody [EP567Y] (ab33875) at 1/500 dilution
All lanes:
RAW264.7 cell lysate at 10 µg
Secondary
All lanes:
HRP goat anti-rabbit (H+L) at 1/1000 dilution
Predicted band size: 52 kDa
Observed band size: 58 kDa
false
Related conjugates and formulations (3)
-
Anti-Smad2 antibody [EP567Y] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Smad2 antibody [EP567Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Smad2 antibody [EP567Y]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Smad2 acts as an intracellular mediator for TGF-β signaling a pathway important for regulating cell proliferation differentiation and apoptosis. Smad2 typically functions as part of a heteromeric complex with Smad4 another key player in TGF-β signaling. Upon activation phosphorylated Smad2 combines with Smad4 to form a complex that translocates into the nucleus. This complex then binds to specific DNA sequences to regulate the transcription of target genes involved in processes such as cell growth inhibition and extracellular matrix production.
Pathways
Smad2 is integral to the TGF-β and activin receptor signaling pathways. These pathways are essential in controlling cell growth and immune responses. Smad2 interacts with other proteins such as Smad3 in addition to Smad4 to modulate gene expression effectively. The interaction between Smad2 and these proteins ensures precise control of cellular responses to external stimuli emphasizing its pivotal role in maintaining cellular homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (94)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:33117 PubMed41006434
2025
Applications
Unspecified application
Species
Unspecified reactive species
Chinese medicine 20:135 PubMed40883748
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of thoracic disease 17:4238-4248 PubMed40688289
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 26: PubMed40565337
2025
Applications
Unspecified application
Species
Unspecified reactive species
Chemical biology & drug design 105:e70113 PubMed40317895
2025
Applications
Unspecified application
Species
Unspecified reactive species
Clinical, cosmetic and investigational dermatology 18:845-857 PubMed40225311
2025
Applications
Unspecified application
Species
Unspecified reactive species
Research (Washington, D.C.) 8:0619 PubMed39975575
2025
Applications
Unspecified application
Species
Unspecified reactive species
Toxicology and applied pharmacology 496:117260 PubMed39929281
2025
Applications
Unspecified application
Species
Unspecified reactive species
Chinese medicine 20:18 PubMed39910658
2025
Applications
Unspecified application
Species
Unspecified reactive species
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 58:e14368 PubMed39907411
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com